UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K/A

 

Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the fiscal year ended December 27, 2025

 

or

 

Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Commission File No. 000-19621

 

ALT5 SIGMA CORPORATION

(Exact name of registrant as specified in its charter)

 

Nevada   41-1454591

(State or other jurisdiction

of incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

8548 Rozita Lee Avenue, Suite 305, Las Vegas, Nevada   89113
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: 800-400-2247

 

Securities registered pursuant to Section 12(b) of the Act:

 

Common Stock, $0.001 par value

 

ALTS

 

Nasdaq Capital Market

Title of each class   Trading Symbol(s)   Name of each exchange on which registered

 

Securities registered pursuant to Section 12(g) of the Act: None

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. ☐ Yes ☒ No

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. ☐ Yes ☒ No

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes ☐ No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes ☐ No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer”, “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer Non-accelerated filer
Smaller reporting company Emerging growth company    

 

If any emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal controls over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.

 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.

 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). ☐ Yes ☒ No

 

The aggregate market value of the registrant’s common stock held by non-affiliates, based on the closing sales price of such stock on June 27, 2025 was approximately $160.6 million.

 

The number of shares outstanding of the registrant’s common stock as of April 9, 2026 was 127,166,254.

 

 

 

 
 

  

TABLE OF CONTENTS

 

  Page
   
Introductory Statement 3
   
PART IV  
Item 15. Exhibits and Financial Statement Schedules 4
Index to Exhibits 4
Signatures 5

 

2
Table of Contents

 

INTRODUCTORY STATEMENT

 

ALT5 Sigma Corporation is filing this Amendment No. 1 to its Annual Report on Form 10-K for the fiscal year ended December 27, 2025 for the purpose of filing its Compensation Recoupment (Clawback) Policy, as Exhibit 97.1. Other than the filing of this replacement exhibit and the dating of this Amendment, there are no changes to that Annual Report.

 

3
Table of Contents

 

PART IV

 

ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

 

(a) Financial Statements, Financial Statement Schedules and Exhibits

 

3. Exhibits

 

See Index to Exhibits

 

Index to Exhibits

 

Exhibit No.   Description
     
97.1+   Compensation Recoupment (Clawback) Policy.
     
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
     
+   Filed herewith.

 

4
Table of Contents

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or Section 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on our behalf by the undersigned, thereunto duly authorized.

 

April 28, 2026

ALT5 Sigma Corporation

  (Registrant)
     
  By /s/ Tony Isaac
    Tony Isaac
    Chief Executive Officer

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

 

Signature   Title   Date
         
Principal Executive Officer        
         
/s/ Tony Isaac   Chief Executive Officer and Director   April 28, 2026
Tony Isaac        
         
Principal Financial and Accounting Officer        
         
/s/ Steven M. Plumb   Chief Financial Officer   April 28, 2026
Steven M. Plumb        
         
Directors        
         
/s/ Zachary Witkoff   Chairman of the Board   April 28, 2026
Zachary Witkoff        
         
/s/ Zachary Folkman   Director   April 28, 2026
Zachary Folkman        
         
/s/ Dr. Adel Elmissiry, Ph.D   Director   April 28, 2026
Dr. Adel Elmissiry, Ph.D        
         
/s/ John Bitar   Director   April 28, 2026
John Bitar        
         
/s/ Nael Hajjar   Director   April 28, 2026
Nael Hajjar        
         
/s/ Tim Stanley   Director   April 28, 2026
Tim Stanley        

  

5